Trials / Completed
CompletedNCT03503266
Mass Balance Study With MT-7117
An Open-label, Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-MT-7117 After a Single Oral Dose to Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Tanabe Pharma America, Inc. · Industry
- Sex
- Male
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a single-centre, open-label, mass balance study in healthy male subjects utilising a single oral dose of \[14C\] MT 7117.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C] MT-7117 | 14-C MT-7117 |
Timeline
- Start date
- 2018-03-23
- Primary completion
- 2018-05-11
- Completion
- 2018-05-11
- First posted
- 2018-04-19
- Last updated
- 2023-05-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03503266. Inclusion in this directory is not an endorsement.